Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Hanna Roberts to Factor IX

This is a "connection" page, showing publications Hanna Roberts has written about Factor IX.

 
Connection Strength
 
 
 
1.355
 
  1. Gabriel DA, Li X, Monroe DM, Roberts HR. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost. 2004 Oct; 2(10):1816-22.
    View in: PubMed
    Score: 0.234
  2. Chang JY, Monroe DM, Stafford DW, Brinkhous KM, Roberts HR. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B. J Clin Invest. 1997 Aug 15; 100(4):886-92.
    View in: PubMed
    Score: 0.143
  3. Roberts HR, Monroe DM. Prothrombin times on deficient plasma reconstituted with factors IX and X. Am J Hematol. 1994 Nov; 47(3):246.
    View in: PubMed
    Score: 0.117
  4. Monroe DM, Hoffman M, Roberts HR, Hedner U. Progressive improvement in wound healing with increased therapy in haemophilia B mice. Haemophilia. 2013 Nov; 19(6):926-32.
    View in: PubMed
    Score: 0.108
  5. Lefkowitz JB, Monroe DM, Kasper CK, Roberts HR. Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources. Am J Hematol. 1993 Jul; 43(3):177-82.
    View in: PubMed
    Score: 0.107
  6. McCord DM, Monroe DM, Smith KJ, Roberts HR. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. J Biol Chem. 1990 Jun 25; 265(18):10250-4.
    View in: PubMed
    Score: 0.087
  7. Monroe DM, McCord DM, Huang MN, High KA, Lundblad RL, Kasper CK, Roberts HR. Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo. Blood. 1989 May 01; 73(6):1540-4.
    View in: PubMed
    Score: 0.080
  8. McDonald A, Hoffman M, Hedner U, Roberts HR, Monroe DM. Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B. J Thromb Haemost. 2007 Aug; 5(8):1577-83.
    View in: PubMed
    Score: 0.071
  9. McGraw RA, Davis LM, Lundblad RL, Stafford DW, Roberts HR. Structure and function of factor IX: defects in haemophilia B. Clin Haematol. 1985 Jun; 14(2):359-83.
    View in: PubMed
    Score: 0.061
  10. Braunstein KM, Noyes CM, Griffith MJ, Lundblad RL, Roberts HR. Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa. J Clin Invest. 1981 Dec; 68(6):1420-6.
    View in: PubMed
    Score: 0.048
  11. Liles D, Landen CN, Monroe DM, Lindley CM, Read MS, Roberts HR, Brinkhous KM. Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B. Thromb Haemost. 1997 May; 77(5):944-8.
    View in: PubMed
    Score: 0.035
  12. Chung KS, Goldsmith JC, Roberts HR. Isolation and characterization of factor IX Chapel Hill: comparison to normal human factor IX. Bibl Haematol. 1977; 44:68-74.
    View in: PubMed
    Score: 0.034
  13. Hoffman M, Monroe DM, Roberts HR. Cellular interactions in hemostasis. Haemostasis. 1996; 26 Suppl 1:12-6.
    View in: PubMed
    Score: 0.032
  14. Pike IM, Yount WJ, Puritz EM, Roberts HR. Immunochemical characterization of a monoclonal G4,lambda human antibody to factor IX. Blood. 1972 Jul; 40(1):1-10.
    View in: PubMed
    Score: 0.025
  15. Lozier JN, Monroe DM, Stanfield-Oakley S, Lin SW, Smith KJ, Roberts HR, High KA. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B. Blood. 1990 Mar 01; 75(5):1097-104.
    View in: PubMed
    Score: 0.021
  16. Huang MN, Kasper CK, Roberts HR, Stafford DW, High KA. Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptide. Blood. 1989 Feb 15; 73(3):718-21.
    View in: PubMed
    Score: 0.020
  17. Monroe DM, Sherrill GB, Roberts HR. Use of p-aminobenzamidine to monitor activation of trypsin-like serine proteases. Anal Biochem. 1988 Aug 01; 172(2):427-35.
    View in: PubMed
    Score: 0.019
  18. Turner AD, Monroe DM, Roberts HR, Porter NA, Pizzo SV. p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombin. Biochemistry. 1986 Aug 26; 25(17):4929-35.
    View in: PubMed
    Score: 0.017
  19. Pizzo SV, Turner AD, Gonias SL, Monroe DM, Roberts HR, Porter NA. Nontoxic irreversible inhibitors of factors IXa, Xa, and thrombin: potential therapeutic agents for the in vivo regulation of thrombin generation and activity. Ann N Y Acad Sci. 1986; 485:199-203.
    View in: PubMed
    Score: 0.016
  20. Jones ME, Griffith MJ, Monroe DM, Roberts HR, Lentz BR. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa. Biochemistry. 1985 Dec 31; 24(27):8064-9.
    View in: PubMed
    Score: 0.016
  21. Monroe DM, Noyes CM, Straight DL, Roberts HR, Griffith MJ. Activation of normal and abnormal human factor IX with trypsin. Arch Biochem Biophys. 1985 May 01; 238(2):490-6.
    View in: PubMed
    Score: 0.015
  22. Noyes CM, Griffith MJ, Roberts HR, Lundblad RL. Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145. Proc Natl Acad Sci U S A. 1983 Jul; 80(14):4200-2.
    View in: PubMed
    Score: 0.013
  23. Wolberg AS, Monroe DM, Roberts HR, Hoffman MR. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis. 1999 Jun; 10(4):201-10.
    View in: PubMed
    Score: 0.010
  24. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol. 1999 Jan; 19(1):170-7.
    View in: PubMed
    Score: 0.010
  25. Monroe DM, Roberts HR, Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol. 1994 Oct; 88(2):364-71.
    View in: PubMed
    Score: 0.007
  26. Brown PE, Hougie C, Roberts HR. The genetic heterogeneity of hemophilia B. N Engl J Med. 1970 Jul 09; 283(2):61-4.
    View in: PubMed
    Score: 0.005
  27. McLester WD, Roberts HR, Wagner RH. Use of an immunosorbent technique in the study of a PTC inhibitor: a new method for the investigation of blood coagulation. J Lab Clin Med. 1965 Oct; 66(4):682-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)